Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.
Method Article
For creation of highly organized structures of complex tissue, one must assemble multiple material and cell types into an integrated composite. This combinatorial design incorporates organ-specific layered cell sheets with two distinct biologically-derived materials containing a strong fibrous matrix base, and endothelial cells for enhancing new vessels formation.
Many tissues, such as the adult human hearts, are unable to adequately regenerate after damage.2,3 Strategies in tissue engineering propose innovations to assist the body in recovery and repair. For example, TE approaches may be able to attenuate heart remodeling after myocardial infarction (MI) and possibly increase total heart function to a near normal pre-MI level.4 As with any functional tissue, successful regeneration of cardiac tissue involves the proper delivery of multiple cell types with environmental cues favoring integration and survival of the implanted cell/tissue graft. Engineered tissues should address multiple parameters including: soluble signals, cell-to-cell interactions, and matrix materials evaluated as delivery vehicles, their effects on cell survival, material strength, and facilitation of cell-to-tissue organization. Studies employing the direct injection of graft cells only ignore these essential elements.2,5,6 A tissue design combining these ingredients has yet to be developed. Here, we present an example of integrated designs using layering of patterned cell sheets with two distinct types of biological-derived materials containing the target organ cell type and endothelial cells for enhancing new vessels formation in the “tissue”. Although these studies focus on the generation of heart-like tissue, this tissue design can be applied to many organs other than heart with minimal design and material changes, and is meant to be an off-the-shelf product for regenerative therapies. The protocol contains five detailed steps. A temperature sensitive Poly(N-isopropylacrylamide) (pNIPAAM) is used to coat tissue culture dishes. Then, tissue specific cells are cultured on the surface of the coated plates/micropattern surfaces to form cell sheets with strong lateral adhesions. Thirdly, a base matrix is created for the tissue by combining porous matrix with neovascular permissive hydrogels and endothelial cells. Finally, the cell sheets are lifted from the pNIPAAM coated dishes and transferred to the base element, making the complete construct.
Injection of cells and/or single materials alone has shown variable success in other organ systems and limited success in cardiac regeneration.5,7-12 Currently, stem cell-derived cells are delivered to damaged tissue using a variety of delivery methods including: direct cell injection into tissue and perfusion into the blood supply.13-17 Others have implanted cells alone, materials alone and/or in combination with material carriers to help regenerate damaged organs.18-21 This design combines multiple strategies that provide material strength, patterning in multiple materials and multiple cell types.
Specifically, the base acellularized fibrous matrix provides the foundational physical strength to the construct, making it suitable for suturing in into the patient, if necessary. The void spaces in the base matrix are filled with endothelial cells in a neovascular permissive hydrogel22 for rapidly establishing vascularization of the implanted construct. This composite is then integrated with pre-patterned cell sheets that allow enhanced cell-to-cell communication, more closely mimic the native tissue.1,23-25 The overall production process for the layered cellular patch is outlined by the flowchart in Figure 1.
1. Creation of pNIPAAM-coated Plates
2. Creation of Cell Sheets
Note: Cell sheets of primary cells for the target organ can be created using a number of different methods, or by coating tissue culture surfaces with thermo-responsive polymer as described here. Pre-coated thermo-sensitive plates are also offered by a number of vendors.
Note: This protocol is for culture using a 35 mm dish. Briefly, cells are first incubated at 37 °C for a minimum of 24 hr at confluence to establish lateral connections between adjacent cells. To release cell sheets, plates are subjected to temperatures below 32 °C. The cell sheet is then transferred to the strong base fibrous matrix containing a neovascular permissive hydrogel with vascular endothelial cells.
3. Preparation of Foundational Matrix
Note: Various 3D fibrous matrices can be used to layer strong fibrous matrix between the delicate cell sheets. Some examples include: gelfoam, bioglass, natural acellularized materials26 or nanospun materials27,28 The porcine urinary bladder matrix (UBM) used in these studies was generously provided from our collaborator, Dr Badylak.29
4. Seeding Endothelial Cells into a Neovascular Permissive Hydrogel
Note: Endothelial cells can be obtained from a variety of sources, including differentiation from stem or progenitor cells. Here, HuVECs are used.
5. Isolation of Cell Sheets
The flow diagram (Figure 1) shows the overall method of making the multilayered patch. Cell sheets are detached from the pNIPAAM treated plate by dropping the temperature below 32 °C. Then the cell sheet is placed on top of the cross-linked hydrogel containing the endothelial cells seeded into the underlying fibrous matrix (Figure 1). The pretreated thermo-sensitive plates can also be used for creating the cell sheets. Special topological surfaces are used to specifically pattern (<...
The critical steps in the protocol include: coating the plate surfaces with the thermoresponsive polymer and manipulating the cell sheets after cooling the plates. Because different cells exhibit different physical properties, like adhesivity, the lifting time should be optimized for each different cell type. The second, and most significantly challenging component of this protocol, centers on the manipulation of the cell sheet, a critical aspect of methods for tissue assembly. The single cell layer in the cell sheet is ...
We have nothing to disclose.
This work was funded by a New Faculty Award II from the California Institute of Regenerative Medicine (CIRM; RN2-00921-1), NIH-funded National Research Award (F32-HL104924), and CIRM Training Grant (TG21163). Materials were provided by: Glycosan Biosystems Inc / BioTime and Dr. Stephen Badylak (University of Pittsburgh)
Name | Company | Catalog Number | Comments |
Reagents | |||
Calcein-AM | Invitrogen | C3099 | Cell tracker / live dye |
Lysotracker Red | Invitrogen | L7528 | Cell tracker |
Neutral Red | Sigma | N7005 | Visible Cell dye |
pNIPAAM | Sigma Aldrich | 412780250 | Poly(N-isopropylacrylamide) |
Toluene | Sigma Aldrich | 244511-1L | |
Hexane | Sigma Aldrich | 296090-1L | |
RAOSMC | Lonza | R-ASM-580 | Rat Aortic Smooth Muscle Cells |
SmGM2 | Lonza | CC-4149 | Smooth Muscle Media |
HUVEC | Invitrogen | C-003-5C | Human Venous Endothelial Cells |
HyStem | Glycosan/Biotime | ||
Isopropyl alcohol | VWR International | BDH1133-4LP | |
Trypsin | Corning Cellgro | 25-053-C1 | |
PBS | Gibco | 14287-072 | |
FBS | Gibco | 16140-071 | |
Specific Equipment | |||
Filter paper | Ahlstrom | 6310-0900 | |
Buchner Funnel | Sigma Aldrich | Z247308 | |
UpCell Plates | Nunc | 2014-11 | |
UV light | Jelight Company | UVO Cleaner Model No.42 |
Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE
Zapytaj o uprawnieniaThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone